From uncertainty on how to treat patients in the first few weeks to now using steroids such as dexamethasone, a lot has changed in Covid care over the last 5 months.
Gilead CEO Daniel O'Day wrote in an open letter that the drug's ability to reduce hospital stays by four days equates to savings of $12,000 per patient in the US
Gilead said it would offer this price to developed countries around the world in order to create a one-price model that would avoid country-by-country negotiations that could slow down access.
In a new set of protocols, the ministry backtracked from its earlier stance and recommended HCQ in the early course of the disease but not in severe cases.
The non-exclusive licensing agreement covers 127 countries, including India. Remdesivir is currently approved in the US for the emergency Covid treatment.
Gilead Sciences says it will ‘work closely with the health authorities in India to provide guidance on anticipated drug supply based on local incidence and severity of disease’.
The study, conducted on over 1,000 patients, also found that remdesivir is unlikely to be sufficient as a standalone treatment as it didn't significantly reduce the death rate.
For an industry globally classified as hazardous, protections such as health insurance and a provident fund for workers are necessities. In Sivakasi, they remain elusive.
The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.
Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.
It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.
It is surprising that high priced drugs like remdesivir and favipiravir are accepted without any sufficiently successful clinically controlled double blind studies, but when Desi Ramdev baba takes the trials successfully, the system is not even ready to examine whether his results are authentic. So much for presence of powerful Pharma lobby.
It is surprising that high priced drugs like remdesivir and favipiravir are accepted without any sufficiently successful clinically controlled double blind studies, but when Desi Ramdev baba takes the trials successfully, the system is not even ready to examine whether his results are authentic. So much for presence of powerful Pharma lobby.